Role of copper and cholesterol association in the neurodegenerative process
- PMID: 24288650
- PMCID: PMC3830777
- DOI: 10.1155/2013/414817
Role of copper and cholesterol association in the neurodegenerative process
Abstract
Age is one of the main factors involved in the development of neurological illnesses, in particular, Alzheimer, and it is widely held that the rapid aging of the world population is accompanied by a rise in the prevalence and incidence of Alzheimer disease. However, evidence from recent decades indicates that Cu and Cho overload are emerging causative factors in neurodegeneration, a hypothesis that has been partially investigated in experimental models. The link between these two variables and the onset of Alzheimer disease has opened up interesting new possibilities requiring more in-depth analysis. The aim of the present study was therefore to investigate the effect of the association of Cu + Cho (CuCho) as a possible synergistic factor in the development of an Alzheimer-like pathology in Wistar rats. We measured total- and nonceruloplasmin-bound Cu and Cho (free and sterified) contents in plasma and brain zones (cortex and hippocampus), markers of oxidative stress damage, inflammation, and programmed cell death (caspase-3 and calpain isoforms). The ratio beta-amyloid (1-42)/(1-40) was determined in plasma and brain as neurodegenerative biomarker. An evaluation of visuospatial memory (Barnes maze test) was also performed. The results demonstrate the establishment of a prooxidative and proinflammatory environment after CuCho treatment, hallmarked by increased TBARS, protein carbonyls, and nitrite plus nitrate levels in plasma and brain zones (cortex and hippocampus) with a consequent increase in the activity of calpains and no significant changes in caspase-3. A simultaneous increase in the plasma A β 1-42/A β 1-40 ratio was found. Furthermore, a slight but noticeable change in visuospatial memory was observed in rats treated with CuCho. We conclude that our model could reflect an initial stage of neurodegeneration in which Cu and Cho interact with one another to exacerbate neurological damage.
Figures
Similar articles
-
Effects of Copper and/or Cholesterol Overload on Mitochondrial Function in a Rat Model of Incipient Neurodegeneration.Int J Alzheimers Dis. 2013;2013:645379. doi: 10.1155/2013/645379. Epub 2013 Nov 6. Int J Alzheimers Dis. 2013. PMID: 24363953 Free PMC article.
-
Copper-induced alterations in rat brain depends on route of overload and basal copper levels.Nutrition. 2014 Jan;30(1):96-106. doi: 10.1016/j.nut.2013.06.009. Nutrition. 2014. PMID: 24290605
-
Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology.Mol Neurobiol. 2017 Oct;54(8):6471-6489. doi: 10.1007/s12035-016-0155-1. Epub 2016 Oct 11. Mol Neurobiol. 2017. PMID: 27730513
-
Senescence-accelerated OXYS rats: a model of age-related cognitive decline with relevance to abnormalities in Alzheimer disease.Cell Cycle. 2014;13(6):898-909. doi: 10.4161/cc.28255. Epub 2014 Feb 17. Cell Cycle. 2014. PMID: 24552807 Free PMC article. Review.
-
Metals, oxidative stress and neurodegenerative disorders.Mol Cell Biochem. 2010 Dec;345(1-2):91-104. doi: 10.1007/s11010-010-0563-x. Epub 2010 Aug 22. Mol Cell Biochem. 2010. PMID: 20730621 Review.
Cited by
-
Dietary cholesterol concentration affects synaptic plasticity and dendrite spine morphology of rabbit hippocampal neurons.Brain Res. 2015 Oct 5;1622:350-60. doi: 10.1016/j.brainres.2015.06.049. Epub 2015 Jul 16. Brain Res. 2015. PMID: 26188241 Free PMC article.
-
Blood-Based Biomarkers for Alzheimer's Disease Diagnosis and Progression: An Overview.Cells. 2022 Apr 17;11(8):1367. doi: 10.3390/cells11081367. Cells. 2022. PMID: 35456047 Free PMC article. Review.
-
Role of Copper in the Onset of Alzheimer's Disease Compared to Other Metals.Front Aging Neurosci. 2018 Jan 23;9:446. doi: 10.3389/fnagi.2017.00446. eCollection 2017. Front Aging Neurosci. 2018. PMID: 29472855 Free PMC article. Review.
-
Serum copper levels are associated with bone mineral density and total fracture.J Orthop Translat. 2018 May 31;14:34-44. doi: 10.1016/j.jot.2018.05.001. eCollection 2018 Jul. J Orthop Translat. 2018. PMID: 30035031 Free PMC article.
-
The many "faces" of copper in medicine and treatment.Biometals. 2014 Aug;27(4):611-21. doi: 10.1007/s10534-014-9736-5. Epub 2014 Apr 20. Biometals. 2014. PMID: 24748564 Free PMC article. Review.
References
-
- Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Archives of Neurology. 2003;60(8):1119–1122. - PubMed
-
- Bagnati PM, Allegri RF, Kremer J, Taragano FE. Enfermedad de Alzheimer y Otras Demencias. Ed. Polemos; 2010.
-
- Foster HD. Why the preeminent risk factor in sporadic Alzheimer’s disease cannot be genetic. Medical Hypotheses. 2002;59(1):57–61. - PubMed
-
- Salustri C, Barbati G, Ghidoni R, et al. Is cognitive function linked to serum free copper levels? A cohort study in a normal population. Clinical Neurophysiology. 2010;121(4):502–507. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials